Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2014
07/31/2014WO2014083040A3 Progranulin as marker for autoimmune disorders
07/31/2014WO2013063186A3 Monoclonal antibodies and methods of use
07/31/2014US20140215644 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
07/31/2014US20140212946 Non-natural ribonuclease conjugates as cytotoxic agents
07/31/2014US20140212500 Compositions containing diverse natural antigens and uses thereof in balancing immune responses
07/31/2014US20140212481 Immunological methods and compositions for the treatment of alzheimer's disease
07/31/2014US20140212473 Glycopeptide and uses thereof
07/31/2014US20140212463 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
07/31/2014US20140212455 Recombinant bcg strains with enhanced ability to inhibit intracellular mycobacterial growth
07/31/2014US20140212454 Prevention of salmonella recrudescense
07/31/2014US20140212449 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
07/31/2014US20140212448 Klebsiella antigens
07/31/2014US20140212446 Novel Artificial Antigen Presenting Cells and Uses Thereof
07/31/2014US20140212445 Use of modified cells for the treatment of multiple sclerosis
07/31/2014US20140212444 Compositions and methods for inducing an immune response
07/31/2014US20140212441 Pharmaceutical composition for inflammatory diseases, allergic diseases and autoimmune diseases
07/31/2014US20140212434 Multivalent vaccines for rabies virus and filoviruses
07/31/2014US20140212431 Pcsk9-binding polypeptides and methods of use
07/31/2014US20140212430 Multiple-variable dose regimen for treating tnfalpha-related disorders
07/31/2014US20140212425 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis
07/31/2014US20140212422 Methods for treating cancer using anti-pd-1 antibodies in combination with anti-ctla-4 antibodies
07/31/2014US20140212421 Methods and compositions for enhanced delivery of macromolecules
07/31/2014US20140212420 Soluble tumor necrosis factor receptor treatment of medical disorders
07/31/2014US20140212419 Ester-based insulin prodrugs
07/31/2014US20140212414 Combination therapy using p53 activator and c-met inhibitor
07/31/2014US20140212413 Methods of Treating TNF-alpha-Mediated Diseases Using Chimeric TNF-alpha Antibodies
07/31/2014US20140212411 Methods of treatment using anti-erbb antibody-maytansinoid conjugates
07/31/2014US20140212410 Co-administration of eribulin and farletuzumab for the treatment of breast cancer
07/31/2014US20140212379 Il-1 binding proteins
07/30/2014EP2759549A2 IL-31 monoclonal antibodies and methods of use
07/30/2014EP2759307A2 Vaccine against Streptococci
07/30/2014EP2759306A1 Immunostimulatory oligonucleotides
07/30/2014EP2759297A1 Combination therapy using p53 activator and c-Met inhibitor
07/30/2014EP2758525A2 Influenza virus mutant expressing a haemagglutinin protein without functional signal sequence for use as vaccine
07/30/2014EP2758513A1 Modified gram positive bacteria and uses thereof
07/30/2014EP2758437A2 Cd27l antigen binding proteins
07/30/2014EP2758434A2 Anti-tumor necrosis factor-alpha agents and uses thereof
07/30/2014EP2758433A1 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
07/30/2014EP2758432A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
07/30/2014EP2758430A1 Anti-c-met antibodies
07/30/2014EP2758422A1 Modified albumin-binding domains and uses thereof to improve pharmacokinetics
07/30/2014EP2758129A2 Laser adjuvants for enhancing immune response
07/30/2014EP2758080A1 Cancer immunotherapy
07/30/2014EP2758079A1 Methods using liver disease biomarkers
07/30/2014EP2758078A1 Anti-hla-dr antibodies suppress allogeneic and xenogeneic immune responses to organ transplants
07/30/2014EP2758077A2 Compounds for use in the treatment of alzheimer's disease
07/30/2014EP2758076A1 Combination therapy using immunoglobulin and c1-inhibitor
07/30/2014EP2758075A1 Influenza virus vaccines and uses thereof
07/30/2014EP2758074A2 Bacterial strains expressing methylase genes and uses thereof
07/30/2014EP2758073A1 Vegf/dll4 binding agents and uses thereof
07/30/2014EP2758072A1 Vaccibodies targeted to cross-presenting dendritic cells
07/30/2014EP2758071A1 Vaccine therapy
07/30/2014EP2758055A1 Combination treatments comprising c-met antagonists and b-raf antagonists
07/30/2014EP2758038A2 Novel influenza hemagglutinin protein-based vaccines
07/30/2014CN103958679A 变异型α-辅肌动蛋白-4的抗体 Variant α- actinin-4 antibody
07/30/2014CN103958545A 犬源化肿瘤坏死因子抗体及其使用方法 Dog humanized TNF antibody and method of use
07/30/2014CN103958544A 针对艰难梭菌的主要外毒素TcdA和TcdB的中和抗体 For the primary C. difficile exotoxin TcdA and TcdB neutralizing antibodies
07/30/2014CN103958543A 治疗肽 Therapeutic peptide
07/30/2014CN103958542A 经修饰的白蛋白结合结构域及其用于改善药代动力学的用途 Modified albumin binding domain and used to improve the pharmacokinetics of the use of
07/30/2014CN103957939A 癌症免疫治疗 Cancer immunotherapy
07/30/2014CN103957938A 治疗多发性骨髓瘤相关障碍的抗icam-1抗体 Treatment of multiple myeloma-related disorders anti-icam-1 antibody
07/30/2014CN103957937A 用于治疗阿尔茨海默病的化合物 Compounds for the treatment of Alzheimer's disease
07/30/2014CN103957936A 用于调控电压门控钙通道功能的方法和组合物 Methods for modulating voltage-gated calcium channel function and composition
07/30/2014CN103957935A 抗cgrp或抗cgrp-r抗体或抗体片段用于治疗或预防慢性和急性形式的腹泻的用途 Or anti-anti cgrp use cgrp-r antibody or antibody fragment for the treatment or prevention of diarrhea, chronic and acute forms of
07/30/2014CN103957934A 包含tlr-5作为佐剂的用于经皮肤免疫的疫苗 Tlr-5 containing as an adjuvant for the vaccine immunized skin
07/30/2014CN103957933A 疫苗 Vaccine
07/30/2014CN103957932A 包含最优化的猫白血病病毒包膜基因的重组猫白血病病毒疫苗 Contains optimized feline leukemia virus envelope gene recombinant feline leukemia virus vaccine
07/30/2014CN103957931A 艰难梭状芽胞杆菌毒素a和毒素b蛋白的分离多肽及其用途 Clostridium difficile toxin a and b protein toxin isolated polypeptide and its use
07/30/2014CN103957930A 癌症治疗用疫苗制剂 Vaccine formulation for cancer treatment
07/30/2014CN103957898A 聚合物蛋白微粒 Protein polymer microparticles
07/30/2014CN103957891A 基于流感血凝素蛋白的新颖疫苗 Based on the novel influenza hemagglutinin protein vaccine
07/30/2014CN103957864A 用于口服生物制剂的薄膜包装 Film packaging for oral biologics
07/30/2014CN103952432A 一种表面展示pedv核心抗原coe蛋白重组毕赤酵母菌的制备方法 A surface showing pedv coe core antigen protein in Pichia yeast preparation
07/30/2014CN103952401A 克隆表达优化的非洲猪瘟vp72基因引物序列、基因、核酸疫苗及构建方法 African swine fever vp72 gene cloning and expression of the primer sequences optimized genes, DNA vaccine and construction methods
07/30/2014CN103952378A 自然无血凝性水貂肠炎病毒株mev-nh及其制备方法和应用 No natural mink enteritis virus hemagglutinin of strain mev-nh its preparation method and application
07/30/2014CN103952377A 一种用于羊传染性脓疱病毒分离培养和增殖的细胞系及其制备方法和应用 A cell line and its preparation method and application of sheep contagious pustular virus isolation and proliferation
07/30/2014CN103952376A 培养细胞、增殖和纯化病毒的方法 The method of cultured cells, and purified the virus proliferation
07/30/2014CN103951753A 抗-gitr抗体 Anti--gitr antibody
07/30/2014CN103951752A 新抗-igf-ir抗体及其用途 The new anti--igf-ir antibodies and uses thereof
07/30/2014CN103951749A 一种抗金黄色葡萄球菌eLtaS蛋白的单克隆中和性抗体E4-2的制备及其应用 Preparation and application of an anti-Staphylococcus aureus eLtaS protein monoclonal neutralizing antibodies E4-2's
07/30/2014CN103951748A 一种抗金黄色葡萄球菌eLtaS蛋白的单克隆中和性抗体E4-1的制备及其应用 Preparation and application of an anti-Staphylococcus aureus eLtaS protein monoclonal neutralizing antibodies E4-1's
07/30/2014CN103951745A Kdr肽和包括该肽的疫苗 Kdr including vaccines of the peptides and peptide
07/30/2014CN103948944A 一种广谱抗肿瘤双质粒可复制型dna疫苗 A broad-spectrum anti-tumor pairs of plasmid replication-dna vaccine
07/30/2014CN103948943A 一种可复制型肾癌治疗性dna疫苗 A replicable model of kidney cancer therapeutic vaccine dna
07/30/2014CN103948942A 一种流感病毒通用疫苗及其制备方法 General one influenza virus vaccine and its preparation method
07/30/2014CN103948923A 一种具抗肿瘤协同增效作用的药物组合物 One kind of synergy with anti-tumor pharmaceutical composition
07/30/2014CN103948922A 核仁蛋白抑制剂的医药用途 Medical use nucleolar protein inhibitors
07/30/2014CN103948921A 一种纳米铝佐剂/自体肿瘤疫苗的制备方法 A nano-aluminum adjuvant / autologous tumor vaccine preparation
07/30/2014CN103948920A 一种猪伪狂犬病活疫苗的制备方法 Preparation method of live swine pseudorabies vaccine
07/30/2014CN103948919A 一种狂犬病灭活疫苗的制备方法 Method for preparing inactivated rabies vaccine
07/30/2014CN103948918A 预防水貂出血性肺炎的三价灭活疫苗的制备方法 Preparation Mink hemorrhagic pneumonia prevention trivalent inactivated vaccine
07/30/2014CN103948917A 树突状细胞疫苗的制备方法 Preparation of dendritic cell vaccine
07/30/2014CN103948662A 一种增强动物免疫力的药物组合物 A method of enhancing immunity of the animal a pharmaceutical composition
07/30/2014CN103948622A 羧甲基葡聚糖在制备提高禽流感疫苗抗体阳性率药物中的应用 Carboxymethyl dextran in the preparation of avian influenza vaccine to improve the antibody positive rate medicament
07/30/2014CN103382460B 一株马立克氏病病毒疫苗株及其分离鉴定和应用 A Marek's disease virus vaccine strain and the identification and application of separation
07/30/2014CN103223162B 一株h3n2犬流感病毒株cgd1的应用 A canine influenza virus strains cgd1 h3n2 Application
07/30/2014CN103212069B 可提高抗体滴度的免疫佐剂、其制备方法及应用 Can improve the antibody titer immune adjuvant, and its preparation method and application
07/30/2014CN103146654B 一株人工弱化的鸡传染性支气管炎病毒及其应用 An artificial weakening of avian infectious bronchitis virus and its application
07/30/2014CN103025761B 人源化抗白介素3受体α链抗体 Humanized anti-interleukin-3 receptor α chain antibody
07/30/2014CN102978126B 新颖乳酸菌株、含有其的组合物及其用途 Novel strains of lactic acid bacteria, a composition containing them and their use
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 1823